CC
DNA icon

Casdin Capital’s Ginkgo Bioworks DNA Stock Holding History

Casdin Capital’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$224K Hold
36,493
– – 0.02% 40
2025
Q4 		$303K Hold
36,493
– – 0.02% 37
2025
Q3 		$532K Hold
36,493
– – 0.04% 32
2025
Q2 		$411K Hold
36,493
– – 0.04% 31
2025
Q1 		$208K Hold
36,493
– – 0.02% 42
2024
Q4 		$358K Hold
36,493
– – 0.02% 38
2024
Q3 		$297K Sell
36,493
-1
-0% -$10 0.02% 34
2024
Q2 		$488K Hold
36,494
– – 0.04% 36
2024
Q1 		$1.69M Buy
+36,494
New +$1.89M 0.13% 33
2022
Q2 		– Sell
-105,070
Closed -$16.9M – 44
2022
Q1 		$16.9M Sell
105,070
-3,152
-3% -$614K 0.76% 28
2021
Q4 		$36M Sell
108,222
-71,848
-40% -$34.1M 1.01% 29
2021
Q3 		$83.5M Buy
+180,070
New +$87.7M 2.08% 18

Other funds holding DNA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return